Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Navigating Technology Transfer
Single-Use-Systems: Leachable Study Design for Single-Use Components
Kathryn McGohan,Scientist, Global Manufacturing Sciences & Technology organization at Bristol-Myers Squibb
Benefits of Mixed-Mode Cation Exchange Chromatography: CMM HyperCel™ Sorbent Used for Monoclonal Antibody and Other Recombinant Protein Purification
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
View All Featured ArticlesHeadline News
Novo Nordisk and Anthropic to team up on accelerating drug discovery through Claude
Körber certifies ZETA’s INOSIM Foresight for PAS X MES data integration
TECVAYLI plus DARZALEX FASPRO modelling suggests longer survival in early line relapsed multiple myeloma
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review
Presented by John Duguid, Executive Director, Research & Development at Vericel Corporation and Lori Daane, Pharma Microbiology Sr. Scientific Director at bioMérieux and Mike Brewer, Director, Global Principal Consultant, Regulatory, BioProduction at Thermo Fisher Scientific
01st November 2022
Towards Real Time Release testing: Dissolution prediction of tablets made using Continuous Direct Compression
Presented by Pallavi Pawar of GlaxoSmithKline
21st November 2017
CMC Progression from Early to Late Phase – Practical Considerations for Gene Therapy
Presented by Sarah Thomas, Vice President of Quality at REGENXBIO Inc. and Joanna Zmurko, NGS specialist at PathoQuest
23rd March 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Best Practices for Achieving Virus Safety
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Rationale Design of Valves for Flexible Processing
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
